RE: c-erbB-2/HER/neu

<< Previous Message | Next Message >>
From:"Sebree Linda A." <la.sebree@hosp.wisc.edu>
To:"'Lapin sairaanhoitopiirin ky'" <paivi.sortti@lshp.fi>
Reply-To:
Date:Thu, 03 Jun 1999 14:46:03 -0500
Content-Type:text/plain; charset="iso-8859-1"

Hi Paivi,

We are using Neomarkers HER-2neu at a 1:75 dilution and employ a 20" HIER in
1mM EDTA at pH 8.  Staining takes place on Ventana immunostainers with the
primary Ab being followed by a 1:200 RxM IgG to amplify the signal.  Primary
incubation is for 32".  We are not using this clinically (FISH instead) but
rather for a large breast carcinoma in situ study.

Feel free with any other questions,
Linda

Linda Sebree, HT
University of Wisconsin Hospital & Clinics
Department of Laboratory Medicine
IHC/ISH Laboratory
A4/204-2472
600 Highland Ave.
Madison, WI  53792-2472

Phone:  (608)265-6596
FAX:  (608)263-1568

> -----Original Message-----
> From:	Lapin sairaanhoitopiirin ky [SMTP:paivi.sortti@lshp.fi]
> Sent:	Thursday, June 03, 1999 8:14 AM
> To:	'histonetters'
> Subject:	c-erbB-2/HER/neu
> 
> Dear Netters,
> 
> we are still looking for the ideal staining of c-erbB-2/HER/neu on breast
> cancer. We have the LabVision/Dako - autostainer and Ultravision detection
> system.
> 
> What antibody are you using?
> 
> 
> 
> Päivi Sortti
> LKS/pat.os
> puh: 016-328 4811
> fax: 016-328 4704
> 



<< Previous Message | Next Message >>